[ad_1]
Anti-malaria drug ‘Piramax’ … Clinical trial for COVID-19
The efficacy article ‘Piramax’ of the National Institute of Health is published
“Experimental level of possibility … excessive expectations must be alert”
[앵커]
Like the never-ending global pandemic of COVID-19, aspiration for vaccines and treatments is also high. Claims are spreading that domestically developed drugs already on the market can be used as treatments to end the “pandemic.” Reporter Kang Jung-gyu confirmed if it’s true. “Korean New Testament No. 16” It is ‘Piramax’, an anti-malaria treatment developed by Shinpoong Pharmaceutical in Korea. As it is known to have the effect of suppressing the Corona 19 virus, it has entered clinical trials in Korea, as well as the UK and South Africa. Right now, Shinpoong Pharmaceutical’s share price is increasing tremendously and some people even believe in Piramax. ▲ Is Piramax the ‘terminator’ of Corona 19? Not long ago, the National Institute of Health under the Ministry of Food and Drug Safety published an article saying that Piramax is effective for treating Corona 19. However, experts say that it is at the level of mentioning the possibility in the experimental stage, and you should be careful of excessive expectations. Clinical trials to use Piramax as a treatment for COVID-19 are still in the second stage, As such, there are only 18 drugs currently in clinical trials by pharmaceutical companies. ▲ Does Piramax have a greater preventive effect than the vaccine? Is it possible to take a drug that has not exceeded the Ma phase 3 clinical threshold for preventive purposes? Experts say it is dangerous agitation. The desire to end the Corona 19 pandemic and the driving force behind the development of treatments are also the driving force, but excessive blind faith can be poison. YTN Kang Jeong-gyu[[email protected]]it is.
